ArticleThe Journal of biological chemistry2026
Direct interaction between human DDX1 and SARS-CoV-2 nucleocapsid protein is regulated by phosphorylation.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An ATP-Driven N Protein-DDX21 Molecular Switch Dynamically Controls SARS-CoV-2 RNA G-Quadruplex Heterogeneity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The nucleocapsid (N) protein of SARS-CoV-2 is essential for viral replication and transcription, in part through interactions with host proteins. Here, we delineate distinct mechanisms underlying N protein association with human RNA helicases DDX1 and DDX21. Co-immunoprecipitation assays in HEK293 cells modified to express N protein revealed that DDX1 binding requires the N protein serine-arginine (SR) region, as SR deletion markedly reduced interaction. Inhibition of glycogen synthase kinase-3 (GSK-3), which targets the SR region, serine-to-alanine substitutions within the SR region, and alkaline phosphatase treatment of extract, respectively, demonstrated that phosphorylation of the SR region is critical for DDX1 binding. Furthermore, phosphorylated or phospho-mimetic SR peptides both prevented N protein-DDX1 complex formation and disrupted preformed complexes in vitro, whereas unphosphorylated peptides had no effect, confirming a phosphorylation-dependent binding mechanism. In contrast, interaction with DDX21 was unaffected by SR deletion or phosphorylation status and required both the N- and C-terminal domains of the N protein. RNase treatment enhanced N-DDX21 association without altering N-DDX1 interactions, indicating distinct regulation by RNA. Domain mapping of the two helicases identified the DDX1 N-terminal and the DDX21 C-terminal domains as interfaces that bind the N protein. Together, these findings support phosphorylation-dependent recruitment of DDX1 versus phosphorylation-independent engagement of DDX21, highlighting mechanistically distinct strategies by which SARS-CoV-2 N co-opts host helicases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.